# Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients

> **NCT05846035** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 80 (estimated)

## Conditions studied

- Hepatocellular Carcinoma Patients

## Interventions

- **DIAGNOSTIC_TEST:** Triphasic C.T abdomen and pelvis

## Key facts

- **NCT ID:** NCT05846035
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-15
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05846035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05846035, "Paraneoplastic Syndrome in Hepatocellular Carcinoma Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05846035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
